Dewar Gaines | CEO & CMO of Gaines Family Farmstead
Dewar Gaines, CEO and CMO of Gaines Family Farmstead, breaks down the scrappy marketing plays behind the brand’s growth—from a low-budget 4th of July Meta ad that crushed, to influencer campaigns that unlocked retention insights, live selling as a zero-CAC growth lever, and the email machine powering 15 sends a month.
We caught up with Dewar Gaines, the CEO and CMO of Gaines Family Farmstead.
In this conversation, we talk through the low-budget 4th of July campaign that crushed, why one influencer partnership failed on conversions but revealed a goldmine in retention, how live selling is becoming their secret weapon for engagement and sales, the underused tactic that drove foot traffic to more than 200 retail stores, and why Dewar still swears by email marketing—sometimes sending up to 15 campaigns a month.
Can you share one marketing campaign you’ve executed (in the pet industry) that you're especially proud of? What made it successful or meaningful to you?
The 4th of July 2024 Holiday META campaign. I took a picture of my barefoot, shirtless son, standing on top of a 4-wheeler, at the top of a mountain, at sunset, waving an American Flag and holding a bag of our best-selling, single-ingredient, Sweet Potato Bones.
I won’t share specifically who we targeted, but it CRUSHED.
Obviously, I am partial to the picture of my namesake, but the simplicity of it is what I love. A picture of a happy kid, celebrating our country and holding a bag of dog treats. No influencer to manage, no UGC, cheap CPM, high conversion rate…. Homerun.
Other Interviews
More conversations with founders, operators, and investors building the future of pet care.
Elizabeth Iorns | Co-Founder & CEO, Familiar Therapeutics
Elizabeth Iorns lost her French Bulldog to a brain tumor that a published canine study suggested could be treated, but no company had taken the drug forward for dogs. Now she and Science Exchange co-founder Dan Knox license the companion animal rights to human drugs at Familiar Therapeutics: 13 programs and $5 million raised in five months, plus a pitch to pharma that pet trials validate targets faster than phase two.
Brian Cheng | Co-Founder, HOLY CAP
HOLY CAP launched in Hong Kong in 2022 selling functional mushroom powders and learned fast that pet owners will not measure another supplement into the bowl. Co-founder Brian Cheng explains the pivot to lickable Squeezees, why in-person sampling beats Amazon at this stage, the operating cost of 14 SKUs split across dogs and cats, and the plan to become a complete-diet brand.
Dennis Gucker & David Franklin | Co-Founders, PawPay
Fewer than 5% of U.S. pets are insured, and PawPay's co-founders think the failure is operational, not emotional. Dennis Gucker explains what carriers told them about the gap between point of sale and point of care, why the company stayed carrier-agnostic, and how real-time coverage scoring plus point-of-care payment changes what clinics can say yes to.